NBER
metadata only
The Strategic Response by Pharmaceutical Firms to the Medicaid Most-Favored-Customer Rules
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Theoretical, psychological, and regulatory dimensions of modern pharmaceutical marketing: implications for patient behavior and healthcare systems#610753
- Understanding the mediating role of pharmaceutical policymaking attitudes between personal attributes and public service motivation#5274
- Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits#649427
- Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits#649426
- Medicare: Selected Prescription Drug Proposals#649415
Record · ID 21503
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive